Patents matching “treatment”

US 11633385

Combination compositions for treatment of cancer

RedHill Biopharma Ltd. · Granted Apr 25, 2023 · Expires Apr 20, 2043

US 11633511

Production of immune-response-stimulating aerosols by non-thermal plasma treatment of airborne pathogens

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 25, 2023 · Expires Apr 20, 2043

US 11634691

Compositions and methods of treatment

The Regents of the University of California · Granted Apr 25, 2023 · Expires Apr 20, 2043

US 11633377

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Apr 25, 2023 · Expires Apr 20, 2043

US 11628146

Estrogen receptor ligand treatment for neurodegenerative diseases

The Regents of the University of California · Granted Apr 18, 2023 · Expires Apr 13, 2043

US 11622991

Protocol for treatment of lupus nephritis

AURINIA PHARMACEUTICALS INC. · Granted Apr 11, 2023 · Expires Apr 6, 2043

US 11623918

Compounds for the treatment of acute and chronic kidney disease

United States Government as represented by the Department of Veterans Affairs · Granted Apr 11, 2023 · Expires Apr 6, 2043

US 11623010

Pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition and methods for treatment

BEIJING RONGXIANG INSTITUTE OF REGENERATIVE MEDICINE CO., LTD. · Granted Apr 11, 2023 · Expires Apr 6, 2043

US 11613739

Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells

REGENXBIO INC. · Granted Mar 28, 2023 · Expires Mar 23, 2043

US 11610666

Systems and methods of managing treatment of a chronic condition by symptom tracking

Corcept Therapeutics Incorporated · Granted Mar 21, 2023 · Expires Mar 16, 2043

US 11608381

Methods of treatment using a leptin receptor agonist antibody

REGENERON PHARMACEUTICALS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

US 11607450

Smallpox vaccine for cancer treatment

Calidi Biotherapeutics, Inc. · Granted Mar 21, 2023 · Expires Mar 16, 2043

US 11607464

Compositions and methods for the treatment and imaging of cancer

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 21, 2023 · Expires Mar 16, 2043

US 11608354

Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease

Theravance Biopharma R&D IP, LLC · Granted Mar 21, 2023 · Expires Mar 16, 2043

US 11607408

Method of treatment of schizophrenia

VANDA PHARMACEUTICALS INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

US 11602551

Use of inosine for the treatment of t-reg deficiency

The Board of Regents of the University of Texas System · Granted Mar 14, 2023 · Expires Mar 9, 2043

US 11603412

Antibodies against CDCP1 for the treatment and detection of cancer

The Regents of the University of California · Granted Mar 14, 2023 · Expires Mar 9, 2043

US 11597773

CD6 antibody for treatment of T-cell mediated diseases or disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 7, 2023 · Expires Mar 2, 2043

US 11596688

Predicting outcome of treatment with an anti-α4β7 integrin antibody

Takeda Pharmaceutical Company Limited · Granted Mar 7, 2023 · Expires Mar 2, 2043

US 11597765

Use of semaphorin-4D binding molecules for the treatment of Rett syndrome

VACCINEX, INC. · Granted Mar 7, 2023 · Expires Mar 2, 2043

US 11598774

Methods of diagnosis and treatment of Alzheimer's Disease

The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

US 11590135

Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

Corcept Therapeutics Incorporated · Granted Feb 28, 2023 · Expires Feb 23, 2043

US 11583530

Compounds for the prevention and treatment of medical disorders and uses thereof

Galectin Sciences, LLC · Granted Feb 21, 2023 · Expires Feb 16, 2043

US 11583529

Treatment of inflammatory disorders

Aldeyra Therapeutics, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043